Mount Sinai names new chief financial officer

Mount Sinai Health System has named Niyum Gandhi as its new chief financial officer.

Mount Sinai is the largest academic medical system in New York City, with eight hospitals, a medical school and a large network of ambulatory services throughout New York. Gandhi served as executive vice president and chief population health officer at Mount Sinai since 2015. He will replace Donald Scanlon, who is departing his role later this year.

As CFO, Gandhi will provide strategic oversight for Mount Sinai’s population health efforts, according to a press release. Gandhi has been leading the health system’s population health initiatives for the last five years, helping Mount Sinai move from fee-for-service to value-based care.

“Niyum has been a trusted and innovative leader, and he is a member of Mount Sinai’s senior leadership team,” Kenneth L. Davis, MD, president and CEO of the Mount Sinai Health System, said in a statement. “He has developed and successfully implemented a new revenue strategy for our system that has resulted in improved value for the patients we serve. As CFO, Niyum will lead our overall financial strategy to ensure our continued innovation and growth. His broad health care and financial acumen will help us meet challenges head on as the health care industry continues to evolve.”

In his previous role, Gandhi also led the clinically integrated network of the health system, known as Mount Sinai Partners. This includes the system’s hospitals, physicians and associated community doctors under a value-based care model. Prior to coming to Mount Sinai, Gandhi was a partner at global management consulting firm Oliver Wyman.

Scanlon served at Mount Sinai since 2003, overseeing a turnaround that brought the health system to positive net income in 2005. The health system credits Scanlon with improving revenue capture and cash collection, according to the announcement.

“Don Scanlon has served a critical role in the expansion of our health system during very challenging times,” Davis said. “He is a visionary leader who has served our community with dedication and distinction and we are grateful he will work closely with Niyum during this transition."

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.